Amlodipine and Olmesartan Market

Amlodipine is a calcium channel blocker. It works by relaxing the muscles of your heart and blood vessels. Olmesartan is an angiotensin II receptor antagonist. Olmesartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. The combination of amlodipine and olmesartan is used to treat high blood pressure (hypertension).
Amlodipine and Olmesartan Market contains market size and forecasts of Amlodipine and Olmesartan in global, including the following market information:
Global Amlodipine and Olmesartan Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Amlodipine and Olmesartan Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Amlodipine and Olmesartan companies in 2021 (%)
The global Amlodipine and Olmesartan market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5/20 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Amlodipine and Olmesartan include Daiichi Sankyo, Teva, Glenmark Pharmaceuticals, Matrix Laboratories, Torrent Pharmaceuticals, Aurobindo, Macleods Pharmaceuticals, Alembic Pharmaceuticals and Ajanta Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Amlodipine and Olmesartan manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Amlodipine and Olmesartan Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amlodipine and Olmesartan Market Segment Percentages, by Type, 2021 (%)
5/20 mg Tablets
10/20 mg Tablets
5/40 mg Tablets
10/40 mg Tablets
Global Amlodipine and Olmesartan Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amlodipine and Olmesartan Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug store
Global Amlodipine and Olmesartan Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Amlodipine and Olmesartan Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Amlodipine and Olmesartan revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Amlodipine and Olmesartan revenues share in global market, 2021 (%)
Key companies Amlodipine and Olmesartan sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Amlodipine and Olmesartan sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Daiichi Sankyo
Teva
Glenmark Pharmaceuticals
Matrix Laboratories
Torrent Pharmaceuticals
Aurobindo
Macleods Pharmaceuticals
Alembic Pharmaceuticals
Ajanta Pharma
Jubilant Pharma
Accord Healthcare